In a recent study, a team of researchers put the Lung CT Screening Reporting and Data System (Lung-RADS™) developed by the ACR to the test with the goal of producing a lower false-positive rate than the 23.3 percent reported by the National Cancer Institute’s National Lung Screening Trial (NLST). In line with their goal, researchers found the Lung-RADS false-positive rate was substantially lower than that of NLST at just 10.4 percent.
The full article is available here.
HealthMyne’s new Cancer Screening Module automates calculations of Lung-RADS scores and more provides more consistent measurements of lesions. New features available in Quantitative Imaging Decision Support (QIDS)™ 5 use Lung-RADS scores to populate a worklist that prioritizes the patients based on their scores combined with other pertinent information, making sure that patients that need attention receive it right away. For sites looking to achieve the benefits of Lung-RADS more efficiently and accurately, HealthMyne can help.